These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2873833)

  • 21. Identification of disulfide-linked transforming growth factor-beta 1-specific binding proteins in rat glomeruli.
    MacKay K; Robbins AR; Bruce MD; Danielpour D
    J Biol Chem; 1990 Jun; 265(16):9351-6. PubMed ID: 2160974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A surface component on GH3 pituitary cells that recognizes transforming growth factor-beta, activin, and inhibin.
    Cheifetz S; Ling N; Guillemin R; Massagué J
    J Biol Chem; 1988 Nov; 263(33):17225-8. PubMed ID: 2903159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the transforming growth factor beta-like activity of synthetic polypeptides comprising the amino-terminal sequence of human parathyroid hormone-related peptide.
    Kikuchi H; Shigeno C; Lee K; Ohta S; Shiomi K; Ikeda T; Sone T; Dokoh S; Konishi J
    Endocrinology; 1991 Mar; 128(3):1229-37. PubMed ID: 1999144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin.
    O'Connor-McCourt MD; Wakefield LM
    J Biol Chem; 1987 Oct; 262(29):14090-9. PubMed ID: 2443501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and binding of radioactively labeled porcine transforming growth factor type beta.
    Ruff E; Rizzino A
    Biochem Biophys Res Commun; 1986 Jul; 138(2):714-9. PubMed ID: 2874805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.
    Anzano MA; Roberts AB; Smith JM; Sporn MB; De Larco JE
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6264-8. PubMed ID: 6604914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antiproliferative effect of type beta transforming growth factor occurs at a level distal from receptors for growth-activating factors.
    Like B; Massagué J
    J Biol Chem; 1986 Oct; 261(29):13426-9. PubMed ID: 2875996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A binding assay for the solubilized receptors of type beta transforming growth factor: adsorption and removal of free ligand by dextran-coated charcoal.
    Fanger BO; Sporn MB
    Anal Biochem; 1986 Aug; 156(2):444-53. PubMed ID: 2429585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A transforming growth factor beta (TGF-beta) receptor from human placenta exhibits a greater affinity for TGF-beta 2 than for TGF-beta 1.
    Mitchell EJ; O'Connor-McCourt MD
    Biochemistry; 1991 Apr; 30(17):4350-6. PubMed ID: 2021626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor.
    Massague J; Czech MP; Iwata K; DeLarco JE; Todaro GJ
    Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6822-6. PubMed ID: 6294655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1.
    Keski-Oja J; Lyons RM; Moses HL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6451-8. PubMed ID: 2890433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts.
    Frolik CA; Wakefield LM; Smith DM; Sporn MB
    J Biol Chem; 1984 Sep; 259(17):10995-1000. PubMed ID: 6088525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Covalent binding of growth hormone to surface receptors on rat adipocytes.
    Gorin E; Goodman HM
    Endocrinology; 1984 Apr; 114(4):1279-86. PubMed ID: 6323141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiplicity of transforming growth factors in human malignant effusions.
    Seo MK; Lynch KE; Podolsky DK
    Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors.
    Cheifetz S; Weatherbee JA; Tsang ML; Anderson JK; Mole JE; Lucas R; Massagué J
    Cell; 1987 Feb; 48(3):409-15. PubMed ID: 2879635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covalent attachment of 125I-beta nerve growth factor to its receptors on sympathetic neurons.
    Stach RW; Rusenko KW
    J Neurosci Res; 1984; 11(3):215-29. PubMed ID: 6330376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and characterization of a novel transforming growth factor.
    Halper J; Moses HL
    Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type beta transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts.
    Ignotz RA; Massagué J
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8530-4. PubMed ID: 3001708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.
    Carr BI; Hayashi I; Branum EL; Moses HL
    Cancer Res; 1986 May; 46(5):2330-4. PubMed ID: 3008986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.